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CASE REPORT
INTRODUCTION
Adenoid cystic carcinoma (ACC) is a rare tumor main-
ly occurring in the salivary glands (parotid glands, sub-
mandibular glands, sublingual glands, and minor salivary
glands).1,2 ACC uncommonly may also arise in other body
sites including lacrimal glands,3 upper respiratory sys-
tem,4-5 breast,6 prostate7 and female low reproductive or-
gans.8 Primary ACC in the liver is extremely rare with
only one case having been reported in the literature.9 Here
we present an unusual case of ACC in the liver with no tu-
mor found in other organs except involvement of adjacent
diaphragm and omentum. We favor this is a primary ade-
noid cystic carcinoma in the liver. We performed his-
topathologic and immunohistochemical analysis and
provided treatment and followup information.
CASE REPORT
This is a 44 years old male presenting with upper ab-
dominal distension for three months and upper abdominal
pain for one week. Physical examination revealed the liver
to be extending to 10 cm beyond the rib contour. No liver
tenderness was present. Physical examination revealed no
jaundice or spider angioma (spider nevus). There was no
edema in his body. Superficial lymph nodes were not pal-
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A B S T R A C T
Adenoid cystic carcinoma (ACC) is an uncommon tumor primarily occurring in the salivary glands and is relatively rare in other sites.
In the liver, only one primary adenoid cystic carcinoma has been reported in the English literature. Here we presented a primary hepatic
adenoid cystic carcinoma in a 44 years old male. We described its histopathologic features and its immunohistochemical
profile, and reviewed the literature. The surgical treatment and patient follow up information was also presented.
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pable. Ultrasound examination showed an abnormal liver
with a mass in the left lobe with a mixed echo signal and
no increased blood flow (Figure 1A). A subsequent com-
puterized tomography examination (Figure 1B) revealed a
21.0 x 16.0 cm mass with an irregular border in the left
lobe of the liver. His complete blood counts, total bi-
lirubin, and protein levels were all within normal ranges.
Liver enzymes alanine transaminase (ALT) and aspartate
aminotransferase (AST) were within normal ranges but
gamma-glutamyl transferase (GGT) was elevated (155 U/L,
normal range 7-50 U/L). His HbsAg test was negative. Se-
rum AFP and CEA levels were within normal ranges.
CA19.9 was elevated to 108.6 U/mL (normal 0-30 U/mL).
The preoperative clinical diagnosis was a primary liver
cancer and a surgery was scheduled. During the operation,
a huge liver tumor was found in the left hepatic lobe with
invasion into the liver capsule and adhering to the dia-
phragm. The liver left lobe with adjacent capsule and dia-
phragm was resected. A portion of omentum was also
resected.
The resected liver tissue measured 24.0 x 20.0 x 12.0
cm and sectioning revealed a 22.0 x 18.0 x 11.0 cm mass.
The mass had a solid and cystic cut surface with a blurry
border.  Microscopically the tumor demonstrated pre-
dominantly cribriform growth pattern (90% area) with a
minor component of tubular and solid growth pattern
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(Figure 2). The pseudocysts/pseudoglands within the
cribriform areas were filled with loose myxoid to dense
eosinophilic base membrane-like material (Figures 2B
and 2C). There were occasional true small glandular
structures within the cribriform areas (Figure 2C). A mi-
nor component of solid growth (Figure 2D) and tubular
structures (Figure 2E) was present. The stroma showed
abundant hyalinization which strangulated the tumor
cells into anastomosing trabeculae (Figure 2F). The tu-
mor cells had oval to angulated hyperchromatic nuclei
with scant cytoplasm and indistinct cell border. There
was mild nuclear pleomorphism (Figure 2). The mitotic
count was 1/10 high power fields and there was no atypi-
cal mitosis. Focal tumor cell necrosis was present (5%).
Immunohistochemically both luminal and abluminal
cells showed diffuse positivity for CK7 and CK19, and
their staining intensity was stronger in the luminal cells
than that in the abluminal cells (Figure 3A). Cytokeratin
CK8/18 was diffusely positive in the luminal cells but
only focal weakly positive in the abluminal cells. P63
staining labeled the abluminal cells but not the luminal
cells (Figure 3B) whereas CD117 showed an opposite la-
beling pattern (Figure 3C). Ki-67 proliferation was about
10-15% (Figure 3F).
According to the most recent World Health Organiza-
tion (WHO) diagnostic criteria, the major diagnostic his-
tological criteria for ACC include biphasic cell
population (luminal and abluminal cells) and variable
growth patterns including tubules, solid and cribriform
architecture.10 The tumor in our case demonstrated bipha-
sic cell population with predominantly cribriform growth
with focal solid and tubular structures. Therefore, this
tumor fulfills the histologic criteria for ACC.10 The histo-
logic diagnosis was further confirmed by immuno-
histochemical stains which labeled two distinct cell
populations (luminal cells CK8 / 18 diffuse+, p63-,
CD117+; abluminal cells CK8 / 18 focal +, p63+,
CD117-).
This tumor also invaded through the liver capsule and
involved adjacent diaphragm. The omentum also con-
tained several tumor nodules ranging from 1.2 to 5.4 cm.
The tumor in the diaphragm and omentum showed simi-
lar histologic features to that in the liver.
After the diagnosis of adenoid cystic carcinoma was
made, the patient underwent whole body PET-CT which
revealed no tumor in other body sites including salivary
glands, other head and neck sites, lung and prostate, etc.
Based on these findings, his liver tumor was most consist-
ent with a primary hepatic adenoid cystic carcinoma.
After the surgery, the patient refused to receive chemo-
therapy and radiation therapy due to financial issue. On his
lobe of followup at 26 months after surgery, magnetic reso-
nance imaging showed tumor recurrence in the right lobe
of his liver, diaphragm, omentum and retroperitoneum.
There was no disease in other body sites on imaging stud-
ies. The patient died of disease at 33 months after surgery.
Figure 1. Ultrasound examination (A) revealed a mixed echo mass within the left lobe of the liver and the tumor was too large to be measured by this meth-
od. Computerized tomography examination (B) revealed a large mass approximately 21.0 cm x 16.0 cm with a mixed density and an irregular border in the left
hepatic lobe.
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Figure 2. Microscopic features of primary hepatic adenoid cystic carcinoma. There is a thick capsule between the tumor (left lower) and the adjacent liver tis-
sue (right upper, A, 20x). The predominant growth pattern of this tumor is cribriform (B, 100x). The cystic spaces within the cribriform area are predominantly
pseudocysts filled with loose myxoid material (B, 100x) and eosinophilic base membrane-like material (C, 200x) but there are occasional true small glands (C,
200x). This tumor contains only focal solid growth (D, 200x) and tubular structures (E, 200x). There is abundant hyalinization in the stroma in some areas which
compressed the tumor cells into anastomosing strands (F, 200x).
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DISCUSSION
In this report, we presented a unique case of ACC in the
liver. The tumor invaded the liver capsule and also involved
adjacent diaphragm and omentum. This patient had no tu-
mor in other sites including the head and neck region, up-
per respiratory tract and genital tract at the time of initial
presentation and followup at 26 months on imaging study.
This tumor demonstrated typical morphologic features and
immunohistochemical profile of ACC, according to the
WHO criteria.10 This case was reviewed in the departmen-
tal consensus conference and was also seen by two patholo-
gists in consultation in two other outside hospitals.
Adenoid cystic carcinoma is a relatively uncommon tu-
mor, most commonly in the salivary glands but it may also
occur in other body sites including upper aerorespiratory
tract, breast and the genital tract etc. It is very rare as a pri-
mary tumor in other sites. In the liver, only one primary
adenoid cystic carcinoma has been reported in the English
literature.9 The patient in that study9 was a 21-years old fe-
male who presented with a 30 cm mass during her preg-
nancy. The tumor almost occupied the whole liver. In our
case, the tumor was 21 cm in size. In the liver, the tumor
can grow to a large size probably due to the intraabdomi-
nal location that can give the tumor more room to grow
before symptoms became evident.
We favor our case is a primary ACC of the liver. Our
case is the second case of primary ACC in the literature.
We favor a primary ACC of the liver based on the follow-
ing facts. Firstly, this tumor formed a single mass in the
liver at the time of initial surgery and there was no evi-
dence of tumor in any other organ including lung and sali-
vary gland at that time. Metastasis typically forms multiple
nodules within the liver. Secondly, during his followup at
Figure 3. Immunohistochemical staining results of primary hepatic adenoid cystic carcinoma. Cytokeratin 7 is diffusely positive in the tumor cells and shows
stronger staining in the luminal cells than abluminal cells (A, 200x). P63 staining labels abluminal cells but not luminal cells (B, 200x). CD117 staining labels
luminal cells but not abluminal cells (C, 200x). The Ki-67 proliferation index in this tumor is about 10-15% (D, 200x).
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26 months (with imaging study), there was still no tumor
in another organ except recurrence in the liver, dia-
phragm, omentum and retroperitoneum. Thirdly, other
types of salivary gland type tumors have been reported as
primary tumors in the liver and bile duct system including
mucoepidermoid carcinoma, myoepithelial carcinoma,
and epithelial-myoepithelial carcinoma.11-17 Primary mu-
coepidermoid carcinoma has been also reported in the
pancreas and ascending colon.18,19 There are two possible
explanation for the histogenesis of primary salivary gland
type tumors in the liver, pancreatobiliary tract and intesti-
nal tract:
• Stem / Reserve cells transdifferentiate into salivary
gland type tumors during malignant transformation
(more likely).19
• These tumors may arise from ectopic salivary gland tissue.
Salivary gland heterotopia/choristoma is typically seen
in the head and neck region but it can be seen in the gas-
trointestinal tract including esophagus, small bowel, co-
lon and rectum.20-23 So far there has been no report of
salivary gland heterotopia/choristoma in the liver and
bile duct system, but this possibility cannot be entirely
excluded.
The major differential diagnosis for our case is a meta-
static adenoid cystic carcinoma from another site. Among
the adenoid cystic carcinomas in the head and neck region,
a significant percentage of them (20 to 50%) will develop
distant metastasis at the time of presentation or in the sub-
sequent disease course.24-27 Lung is the most common site
of metastasis followed by bone whereas brain and liver are
much less common sites for metastasis.24-30 Liver is rarely
the only site of metastasis.24-30 Liver metastasis may be the
first sign of presentation.15-16 Besides adenoid cystic carci-
noma of salivary glands, adenoid cystic carcinoma from
other sites such as vulva,31 trachea,32 lacrimal gland33 has
also been reported to metastasize to the liver. Our patient
did not have any tumor in other sites on imaging studies at
the time of treatment and on followup (26 months after
the surgery). These findings favor the diagnosis of a prima-
ry hepatic ACC as discussed above.
Adenoid cystic carcinoma is a slow growing tumor but
it shows a relentless and progressive disease with 10-year
survival rate less than 50%.27 Surgery is the main treatment.
The postoperative radiotherapy is recommended if the
surgical margin is positive. Because of a poor response,
chemotherapy was not typically recommended as a thera-
peutic option.27 Tumor stage and histologic grade are the
two most important prognostic factors for adenoid cystic
carcinoma in the head and neck region.26,27,34 Solid growth
pattern was associated with a worse prognosis.26,27,34 Our
case showed very focal solid growth (< 5%) and it had a
large size and invaded through liver capsule into dia-
phragm and omentum, indicating an advanced stage. The
disease recurred at 26 months and died at 33 months after
surgery, speaking itself for its relentless and progressive
disease course.
In summary, we presented a unique case of ACC in a 44
years old male patient in his liver and we favor this is a
primary hepatic ACC. The carcinoma demonstrated typi-
cal morphologic and immunohistochemical profile of ade-
noid cystic carcinoma.
ABBREVIATIONS
• ACC: adenoid cystic carcinoma.
• ALT: alanine transaminase.
• AST: aspartate aminotransferase.
• GGT: gamma-glutamyl transferase.
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